Nonocclusive Mesenteric Ischemia in Aortic Surgery: What You Need to Know
Related Experiment Video
Updated: Jul 13, 2026

Reproducible Motor Deficit Following Aortic Occlusion in a Rat Model Of Spinal Cord Ischemia
Published on: July 22, 2017
Ali Murtada1, Matti Jubouri2, Mohamed Refaie1
1Department of General Surgery, Glan Clwyd Hospital, Rhyl, UK.
Background:
Nonocclusive mesenteric ischemia (NOMI), a subtype of acute mesenteric ischemia (AMI), is primarily caused by mesenteric arterial vasoconstriction and decreased vascular resistance, leading to impaired intestinal perfusion.Commonly observed after cardiac surgery, NOMI affects older patients with cardiovascular or systemic diseases, accounting for 20-30% of AMI cases with a mortality rate of ∼50%. This review explores NOMI's pathophysiology, clinical implications in aortic dissection, and the unmet needs in diagnosis and management, emphasizing its prognostic significance.
Methods:
A comprehensive literature review was conducted using multiple electronic databases to extract relevant data and information.
Results:
NOMI is a life-threatening condition characterized by mesenteric vasoconstriction and reduced splanchnic blood flow, often triggered by cardiac surgery, hemodialysis, or hypotensive episodes. Epidemiological studies highlight its prevalence in intensive care unit settings, with a high mortality rate linked to delayed diagnosis and systemic hypoperfusion. Risk factors include advanced age, vasopressor use, and inflammatory markers. Biomarkers such as intestinal fatty acid binding protein, citrulline, and D-lactate show potential for early detection but lack robust clinical validation. Management includes fluid resuscitation, vasodilators, and surgical intervention for bowel necrosis. Emerging endovascular approaches show promise but are limited to select cases without bowel infarction. This review underscores the critical need for timely diagnosis, risk factor identification, and tailored interventions to improve outcomes.
Conclusion:
NOMI remains poorly understood despite advances in surgical and perioperative care. Its pathophysiology, linked to cardiopulmonary bypass and intraoperative factors, requires heightened clinical vigilance. Limited evidence underscores the need for a multidisciplinary approach involving surgeons, radiologists, and anesthetists to improve diagnosis, management, and outcomes in aortic surgery patients.
Insights
Nonocclusive mesenteric ischemia (NOMI) is a serious condition often seen after cardiac surgery, causing poor intestinal blood flow. Early diagnosis and a team approach are crucial for improving patient outcomes in this high-mortality disease.
Area of Science:
- Gastroenterology
- Vascular Surgery
- Critical Care Medicine
Background:
- Nonocclusive mesenteric ischemia (NOMI), a subset of acute mesenteric ischemia (AMI), stems from mesenteric arterial vasoconstriction and reduced vascular resistance, impairing intestinal perfusion.
- Frequently occurring post-cardiac surgery, NOMI predominantly affects elderly patients with pre-existing cardiovascular or systemic conditions, representing 20-30% of AMI cases with a substantial mortality rate of approximately 50%.
Purpose of the Study:
- To explore the pathophysiology of NOMI.
- To examine the clinical implications of NOMI in the context of aortic dissection.
- To identify unmet needs in the diagnosis and management of NOMI, highlighting its prognostic significance.
Main Methods:
- A comprehensive literature review was performed utilizing multiple electronic databases to gather pertinent data and information.
Main Results:
- NOMI is a critical condition marked by mesenteric vasoconstriction and diminished splanchnic blood flow, often precipitated by cardiac surgery, hemodialysis, or hypotensive episodes.
- Prevalence is high in intensive care units, with delayed diagnosis and systemic hypoperfusion contributing to elevated mortality. Risk factors include advanced age, vasopressor use, and inflammatory markers.
- Potential early detection biomarkers like intestinal fatty acid binding protein, citrulline, and D-lactate require further clinical validation. Management strategies involve fluid resuscitation, vasodilators, and surgical intervention for bowel necrosis, with endovascular approaches showing promise in select cases.
Conclusions:
- NOMI's pathophysiology, particularly its link to cardiopulmonary bypass and intraoperative factors, necessitates increased clinical awareness.
- A multidisciplinary approach involving surgeons, radiologists, and anesthetists is essential for enhancing the diagnosis, management, and outcomes for patients undergoing aortic surgery.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management

